Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?

S. Faderl, M. Talpaz, H. M. Kantarjian, Z. Estrov

Research output: Contribution to journal › Comment/debate › peer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?'. Together they form a unique fingerprint.